GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Greenyn Biotechnology Co Ltd (ROCO:6846) » Definitions » Other Long Term Assets

Greenyn Biotechnology Co (ROCO:6846) Other Long Term Assets : NT$161.7 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Greenyn Biotechnology Co Other Long Term Assets?

Greenyn Biotechnology Co's other long-term assets for the quarter that ended in Mar. 2024 was NT$161.7 Mil.

Greenyn Biotechnology Co's quarterly other long-term assets increased from Sep. 2023 (NT$33.6 Mil) to Dec. 2023 (NT$102.2 Mil) and increased from Dec. 2023 (NT$102.2 Mil) to Mar. 2024 (NT$161.7 Mil).

Greenyn Biotechnology Co's annual other long-term assets increased from Dec. 2021 (NT$24.8 Mil) to Dec. 2022 (NT$36.0 Mil) and increased from Dec. 2022 (NT$36.0 Mil) to Dec. 2023 (NT$102.2 Mil).


Greenyn Biotechnology Co Other Long Term Assets Historical Data

The historical data trend for Greenyn Biotechnology Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenyn Biotechnology Co Other Long Term Assets Chart

Greenyn Biotechnology Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
27.31 17.39 24.77 36.03 102.16

Greenyn Biotechnology Co Quarterly Data
Dec19 Jun20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 61.94 33.94 33.61 102.16 161.73

Greenyn Biotechnology Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Greenyn Biotechnology Co (ROCO:6846) Business Description

Traded in Other Exchanges
N/A
Address
5th Floor, No 43 Keya Road, Daya District, Taichung, TWN
Greenyn Biotechnology Co Ltd has developed Insumate patented sequenced peptide, Antromax Antrodia cinnamomea mycelia, and Zymologist fermented liquid.

Greenyn Biotechnology Co (ROCO:6846) Headlines

No Headlines